H Clinical Executes Latin America’s Most Significant Home Trial Operation in History
H Clinical provided the logistics and home visit support for Janssen’s NCT04505722 Ensemble clinical trial in Argentina, Brazil, Colombia, Mexico, and Peru. This trial resulted in a single-dose COVID-19 vaccine that received FDA’s emergency use authorization on February 27, 2021, for use in individuals 18 years of age and older. For more information see: FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine | FDA
We simplify complex clinical trials across Latin America.
H Clinical simplifies complex clinical trials to meet the needs of all patients and studies. We are the leader in delivering localized, community-based, patient-centric clinical trial services and home healthcare throughout Latin America. At H Clinical, we’re bringing clinical research home.
-
TAMPA - U.S./CORPORATE HEADQUATERS
7901 4th St N, Suite 5706, St. Petersburg, FL 33702 -
MEXICO CITY – CENTRAL AMERICAN HEADQUARTERS
Av. Insurgentes Sur No1605, Piso 15 Mod IV, Col. San Jose Insurgentes, Del. Benito Juarez, CP 03900, CDMX, Mexico -
SAO PAULO – SOUTH AMERICAN HEADQUARTERS
Rua Salviano Jose Da Silva, No 225, Bairro El Dorado, Sao Jose Dos Campos, SP, Brazil